423
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era

& ORCID Icon
Pages 111-117 | Received 25 Aug 2022, Accepted 22 Dec 2022, Published online: 12 Jan 2023

References

  • Steiner TJ, Stovner LJ, Jensen R., et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. doi:10.1186/s10194-020-01208-0
  • Silberstein SD. Migraine. Lancet. 2004;363:381–391. doi:10.1016/S0140-6736(04)15440-8
  • Steiner TJ, Stovner LJ, Vos T, et al. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19(1):17. doi:10.1186/s10194-018-0846-2
  • Zobdeh F, Ben Kraiem A, Attwood MM, et al. Pharmacological treatment of migraine: drug classes, mechanisms of action, clinical trials and new treatments. Br J Pharmacol. 2021;178:4588–4607. doi:10.1111/bph.15657
  • Yao C, Wang Y, Wang L, et al. Burden of headache disorders in China, 1990-2017: findings from the Global Burden of Disease Study 2017. J Headache Pain. 2019;20:102. doi:10.1186/s10194-019-1048-2
  • Bobker SM, Robbins MS. COVID-19 and Headache: a Primer for Trainees. Headache. 2020;60:1806–1811. doi:10.1111/head.13884
  • Tomkins E, Craven A, Ruttledge M. Migraine and Headache Care in the Republic of Ireland: history and a Vision for the Future Influenced by the COVID-19 Pandemic. Headache. 2020;60:2665–2668. doi:10.1111/head.13985
  • Landis BC, Brooks AE, Digre KB, et al. Coronavirus Disease 2019, Eye Pain, Headache, and Beyond. J Neuroophthalmol. 2022;42(1):18–25. doi:10.1097/WNO.0000000000001526
  • Straburzyński M, Nowaczewska M, Budrewicz S, et al. COVID-19-related headache and sinonasal inflammation: a longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Cephalalgia. 2022;42(3):218–228. doi:10.1177/03331024211040753
  • Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care. 2020;9:2207–2213. doi:10.4103/jfmpc.jfmpc_105_20
  • Hong JS, Wasden C, Han DH. Introduction of digital therapeutics. Comput Methods Programs Biomed. 2021;209:106319. doi:10.1016/j.cmpb.2021.106319
  • Fairburn CG, Patel V. The impact of digital technology on psychological treatments and their dissemination. Behav Res Ther. 2017;88:19–25. doi:10.1016/j.brat.2016.08.012
  • Minen MT, Morio K, Schaubhut KB, et al. Focus group findings on the migraine patient experience during research studies and ideas for future investigations. Cephalalgia. 2020;40(7):712–734. doi:10.1177/0333102419888230
  • Kretzschmar K, Tyroll H, Pavarini G, et al. Can Your Phone Be Your Therapist? Young People’s Ethical Perspectives on the Use of Fully Automated Conversational Agents (Chatbots) in Mental Health Support. Biomed Inform Insights. 2019;11:1178222619829083. doi:10.1177/1178222619829083
  • Fitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): a Randomized Controlled Trial. JMIR Ment Health. 2017;4:e19. doi:10.2196/mental.7785
  • Agosti R. Migraine Burden of Disease: from the Patient’s Experience to a Socio-Economic View. Headache. 2018;58(Suppl 1):17–32. doi:10.1111/head.13301
  • Szperka CL, Ailani J, Barmherzig R, et al. Migraine Care in the Era of COVID-19: clinical Pearls and Plea to Insurers. Headache. 2020;60:833–842. doi:10.1111/head.13810
  • Panayi ND, Mars MM, Burd R. The promise of digital (mobile) health in cancer prevention and treatment. Future Oncol. 2013;9:613–617. doi:10.2217/fon.13.42
  • Heeren A. Commentary: the Impact of Digital Technology on Psychological Treatments and Their Dissemination. Front Psychol. 2018;9:1571. doi:10.3389/fpsyg.2018.01571
  • Minen MT, Torous J, Raynowska J, et al. Electronic behavioral interventions for headache: a systematic review. J Headache Pain. 2016;17:51. doi:10.1186/s10194-016-0608-y
  • Usmani S, Balcer L, Galetta S, et al. Feasibility of Smartphone-Delivered Progressive Muscle Relaxation in Persistent Post-Traumatic Headache Patients. J Neurotrauma. 2021;38:94–101. doi:10.1089/neu.2019.6601
  • Minen MT, Jalloh A, Ortega E, et al. User Design and Experience Preferences in a Novel Smartphone Application for Migraine Management: a Think Aloud Study of the RELAXaHEAD Application. Pain Med. 2019;20(2):369–377. doi:10.1093/pm/pny080
  • Hommel KA, Carmody J, Hershey AD, et al. Digital Therapeutic Self-Management Intervention in Adolescents With Migraine: feasibility and Preliminary Efficacy of “Migraine Manager”. Headache. 2020;60:1103–1110. doi:10.1111/head.13805
  • Minen MT, Jaran J, Boyers T, et al. Understanding What People With Migraine Consider to be Important Features of Migraine Tracking: an Analysis of the Utilization of Smartphone-Based Migraine Tracking With a Free-Text Feature. Headache. 2020;60(7):1402–1414. doi:10.1111/head.13851
  • van de Graaf DL, Schoonman GG, Habibović M, et al. Towards eHealth to support the health journey of headache patients: a scoping review. J Neurol. 2021;268(10):3646–3665. doi:10.1007/s00415-020-09981-3
  • van Casteren DS, Verhagen IE, de Boer I, et al. E-diary use in clinical headache practice: a prospective observational study. Cephalalgia. 2021;41:1161–1171. doi:10.1177/03331024211010306
  • Göbel H. Non pharmaceutical treatments for migraine. Rev Neurol. 2005;161:685–686. doi:10.1016/S0035-3787(05)85117-3
  • Kuruvilla DE, Mehta A, Ravishankar N, et al. A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey. BMC Complement Med Ther. 2021;21(1):58. doi:10.1186/s12906-021-03226-0
  • Buse DC, Rabany L, Lin T, et al. Combining Guided Intervention of Education and Relaxation (GIER) with Remote Electrical Neuromodulation (REN) in the Acute Treatment of Migraine. Pain Med. 2022;23(9):1544–1549. doi:10.1093/pm/pnac021
  • Ailani J, Rabany L, Tamir S, et al. Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine. Front Pain Res. 2021;2:753736. doi:10.3389/fpain.2021.753736
  • Ng QX, Venkatanarayanan N, Kumar L. A Systematic Review and Meta-Analysis of the Efficacy of Cognitive Behavioral Therapy for the Management of Pediatric Migraine. Headache. 2017;57:349–362. doi:10.1111/head.13016
  • Bae JY, Sung HK, Kwon NY, et al. Cognitive Behavioral Therapy for Migraine Headache: a Systematic Review and Meta-Analysis. Medicina. 2021;58. doi:10.3390/medicina58010044
  • Stubberud A, Linde M. Digital Technology and Mobile Health in Behavioral Migraine Therapy: a Narrative Review. Curr Pain Headache Rep. 2018;22:66. doi:10.1007/s11916-018-0718-0
  • Kaufman N, Ferrin C, Sugrue D. Using Digital Health Technology to Prevent and Treat Diabetes. Diabetes Technol Ther. 2019;21:S79–s94. doi:10.1089/dia.2019.2506
  • Cho CH, Lee HJ. Could Digital Therapeutics be a Game Changer in Psychiatry? Psychiatry Investig. 2019;16:97–98. doi:10.30773/pi.2019.01.20
  • Crawford MR, Luik AI, Espie CA, et al. Digital Cognitive Behavioral Therapy for Insomnia in Women With Chronic Migraines. Headache. 2020;60:902–915. doi:10.1111/head.13777
  • Adhikari MTM. Smartphone-based migraine behavioral therapy: a single-arm study with assessment of mental health predictors. NPJ Digit Med. 2019;2:46. doi:10.1038/s41746-019-0116-y
  • Minen MT, Friedman BW, Adhikari S, et al. Introduction of a smartphone based behavioral intervention for migraine in the emergency department. Gen Hosp Psychiatry. 2021;69:12–19. doi:10.1016/j.genhosppsych.2020.12.009
  • Lelleck VV, Schulz F, Witt O, et al. A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: real World Data from Two Prospective Studies. Nutrients. 2022;14(14):2927. doi:10.3390/nu14142927
  • Schröder T, Kühn G, Kordowski A, et al. A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: proof-of-Concept Data from a Retrospective Cohort Study. J Clin Med;2022. 11. doi:10.3390/jcm12010011
  • Drescher J, Wogenstein F, Gaul C, et al. Distribution of migraine attacks over the days of the week: preliminary results from a web-based questionnaire. Acta Neurol Scand. 2019;139:340–345. doi:10.1111/ane.13065
  • Friedman DI, Rajan B, Seidmann A. A randomized trial of telemedicine for migraine management. Cephalalgia. 2019;39:1577–1585. doi:10.1177/0333102419868250
  • Minen MT, Szperka CL, Kaplan K, et al. Telehealth as a new care delivery model: the headache provider experience. Headache. 2021;61:1123–1131. doi:10.1111/head.14150
  • Dodick DW, Tepper SJ, Lipton RB, et al. Improving Medical Communication in Migraine Management: a Modified Delphi Study to Develop a Digital Migraine Tracker. Headache. 2018;58:1358–1372. doi:10.1111/head.13426
  • Kim HS. Apprehensions about Excessive Belief in Digital Therapeutics: points of Concern Excluding Merits. J Korean Med Sci. 2020;35:e373. doi:10.3346/jkms.2020.35.e373
  • Yan K, Balijepalli C, Druyts E. The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks. Front Digit Health. 2021;3:667016. doi:10.3389/fdgth.2021.667016
  • Sverdlov O, van Dam J, Hannesdottir K, et al. Digital Therapeutics: an Integral Component of Digital Innovation in Drug Development. Clin Pharmacol Ther. 2018;104(1):72–80. doi:10.1002/cpt.1036